Simon Green
Director/Board Member chez CLOVER CORPORATION LIMITED
Fortune : 11 465 $ au 31/03/2024
Profil
Simon Green is currently the Chief Executive Officer of Immunosis Pty Ltd.
He is also an Independent Non-Executive Director at Syntara Ltd.
and Clover Corp.
Ltd.
Additionally, he holds the position of Senior Vice President at CSL Behring GmbH.
Dr. Green is a former Independent Non-Executive Director at Acrux Ltd.
He also works as a Venture Partner at Bioscience Managers Pty Ltd.
Dr. Green holds a doctorate degree from the University of Melbourne and an undergraduate degree from Monash University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/07/2023 | 36 234 ( 0,02% ) | 11 465 $ | 31/03/2024 |
Postes actifs de Simon Green
| Sociétés | Poste | Début |
|---|---|---|
| CLOVER CORPORATION LIMITED | Director/Board Member | 20/10/2020 |
| SYNTARA LIMITED | Director/Board Member | 16/12/2022 |
Immunosis Pty Ltd.
 Immunosis Pty Ltd. Pharmaceuticals: MajorHealth Technology Immunosis Pty Ltd. develops pharmaceutical products. The private company is based in Melbourne, Australia. Simon Green has been the CEO of the Australian company since 2015. | Chief Executive Officer | 01/11/2015 |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Private Equity Investor | 01/05/2020 |
CSL Behring GmbH
 CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Part of CSL Ltd., CSL Behring GmbH is a German company that actively collaborates to develop special programs and activities for patients with rare diseases. The private company is based in Marburg, Germany. The CEOs of the company are Lutz Guenter Bonacker, Michael Schröder, Craig Shelanskey. | Private Equity Investor | - |
Anciens postes connus de Simon Green
| Sociétés | Poste | Fin |
|---|---|---|
| ACRUX LIMITED | Director/Board Member | 01/01/2019 |
Formation de Simon Green
| University of Melbourne | Doctorate Degree |
| Monash University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SYNTARA LIMITED | Health Technology |
| CLOVER CORPORATION LIMITED | Health Technology |
| ACRUX LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
CSL Behring GmbH
CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Part of CSL Ltd., CSL Behring GmbH is a German company that actively collaborates to develop special programs and activities for patients with rare diseases. The private company is based in Marburg, Germany. The CEOs of the company are Lutz Guenter Bonacker, Michael Schröder, Craig Shelanskey. | Health Technology |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Finance |
Immunosis Pty Ltd.
Immunosis Pty Ltd. Pharmaceuticals: MajorHealth Technology Immunosis Pty Ltd. develops pharmaceutical products. The private company is based in Melbourne, Australia. Simon Green has been the CEO of the Australian company since 2015. | Health Technology |
